Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Liabilities and Shareholders Equity: 2022-2025

Historic Liabilities and Shareholders Equity for Prokidney (PROK) over the last 4 years, with Sep 2025 value amounting to $351.6 million.

  • Prokidney's Liabilities and Shareholders Equity fell 25.94% to $351.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year decrease of 11.86%. This contributed to the annual value of $441.1 million for FY2024, which is 4.88% up from last year.
  • As of Q3 2025, Prokidney's Liabilities and Shareholders Equity stood at $351.6 million, which was down 5.52% from $372.1 million recorded in Q2 2025.
  • Prokidney's Liabilities and Shareholders Equity's 5-year high stood at $532.4 million during Q3 2022, with a 5-year trough of $250.8 million in Q1 2022.
  • In the last 3 years, Prokidney's Liabilities and Shareholders Equity had a median value of $441.1 million in 2024 and averaged $434.9 million.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first spiked by 97.47% in 2023, then dropped by 25.94% in 2025.
  • Quarterly analysis of 4 years shows Prokidney's Liabilities and Shareholders Equity stood at $518.0 million in 2022, then dropped by 18.81% to $420.6 million in 2023, then increased by 4.88% to $441.1 million in 2024, then dropped by 25.94% to $351.6 million in 2025.
  • Its last three reported values are $351.6 million in Q3 2025, $372.1 million for Q2 2025, and $406.1 million during Q1 2025.